Open AccessPhase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Author(s) -
Rebecca Gelman,
Lisa A. Carey,
Eric P. Winer,
Steven E. Come,
Fred H. Hochberg,
Minetta C. Liu,
Jerry Younger,
David G. Kirsch,
Xiaochun Li,
Harold J. Burstein,
John W. Henson,
Nancy U. Lin,
Annick D. Van den Abbeele,
Gordon J. Harris,
Matthew G. Ewend,
Elizabeth Bullitt,
Ann Crawford,
Elizabeth Kasparian
Publication year - 2008
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/9qk2-5h06
Subject(s) - lapatinib , human epidermal growth factor receptor 2 , cancer , oncology , medicine , breast cancer , epidermal growth factor receptor , cancer research , trastuzumab